← all signals · sectors · research
Denali Therapeutics Inc. DNLI
SIC 2836 — Biological Products, (No Diagnostic Substances) · CIK 1714899
This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).
FY2021 long
3 signals fired ·
match: triple
capex_spike, fcf_turn_negative, profit_to_loss
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +0.57% |
| 60 days | -0.32% |
| 252 days (1y) | -5.43% |
FY2020 long
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +1.81% |
| 60 days | +4.48% |
| 252 days (1y) | +19.70% |
FY2019 short
2 signals fired ·
match: pair
capex_spike, fcf_turn_negative
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.92% |
| 60 days | +1.26% |
| 252 days (1y) | -2.11% |
FY2018 long
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +1.81% |
| 60 days | +4.48% |
| 252 days (1y) | +19.70% |
Methodology: /methodology · Live JSON: /api/company/1714899/financials